Finasteride

Finasteride lowers production of a hormone involved in male pattern hair loss and prostate enlargement. The product and indication matter. A hair-loss prescription should follow an assessment of the cause of shedding rather than assume every change in hair density is male pattern loss. ¹

Sexual adverse effects and fertility concerns require discussion; symptoms have been reported after discontinuation. New or worsening depression should be raised promptly. Pregnancy exposure to broken or crushed tablets is a concern. Tell clinicians about finasteride before interpreting prostate-related tests. ¹

A compounded finasteride mixture needs formulation-specific evidence, exposure precautions and pharmacy identification. It cannot be called approved merely because oral finasteride is approved. Ask which data support the actual product and whether those data address systemic exposure as well as scalp effects.

Finasteride can harm development of a male fetus. People who are or may be pregnant should not handle crushed or broken tablets; intact coated tablets prevent contact during ordinary handling. Small amounts are present in semen, so pregnancy questions should be discussed with the prescriber rather than managed from online rules. Finasteride can also change semen volume and fertility measures in some men. Fertility goals belong in the initial decision and follow-up, particularly when another hormone-related medicine is being considered. ¹

Finasteride lowers prostate-specific antigen values. A clinician interpreting PSA needs to know the product, indication, start date and adherence so a change is not missed or misread. The medicine does not eliminate prostate-cancer risk or replace evaluation of urinary symptoms. New breast lumps, nipple discharge, testicular pain, blood in urine, inability to urinate or a major change in urinary pattern warrants assessment. Do not stop before testing without advice; provide the medication history to the clinician ordering the test. ¹

Topical finasteride and mixtures with minoxidil, tretinoin or vitamins are compounded or otherwise product-specific preparations; oral tablet approval does not establish their absorption, household-transfer risk or safety. Ask for the complete ingredient list, concentration, application area, hand-washing instructions and transfer precautions. A marketing name such as a hair formula cannot replace the pharmacy label. Report sexual, mood, breast or fertility changes rather than adding another hormone medicine to counter an assumed side effect. ¹

Depressed mood and sexual symptoms should be reported, including symptoms that persist after stopping. This does not establish that finasteride caused every symptom, but it supports timely assessment and a documented treatment decision. Suicidal thoughts require urgent help. Before adding testosterone, tadalafil or supplements, review onset, other medicines, endocrine or vascular contributors and the original hair or prostate goal with the prescriber. ¹